Lyka Labs Limited has intimated the stock exchanges (BSE Limited and National Stock Exchange of India Limited) about an upcoming meeting of its Board of Directors. The board meeting is scheduled to be held on Friday, 30th October, 2026.
The primary agenda of the meeting is to consider and approve the company's Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended on 30th September, 2026. The board will also review the Limited Review Report issued by the Statutory Auditor of the Company.
This disclosure is made in compliance with Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has also made this information available on its official website at www.lykalabs.com.
The communication was digitally signed by Shailendra Kumar Agrawal, who serves as the Company Secretary and Compliance Officer of Lyka Labs Limited, from Mumbai on October 14, 2026.